Cannabis Use Disorder, often shortened to CUD, is becoming more visible as cannabis becomes more widely used. While many people use cannabis without major problems, some individuals develop patterns of use that start to affect their thinking, emotional stability, daily habits, and overall health. Clinicians and researchers are working to better identify who may be at risk and how to support recovery effectively. One emerging approach involves combining brain-based evaluation tools with psychological questionnaires to create a clear picture of how cannabis is affecting the mind and body.
This article summarizes findings from a systematic review that looked at both neurophysiological tools and well established psychological screening measures. The goal is to understand how these tools help assess severity, guide treatment planning, and support long-term recovery.
Brain-Based Tools That Show How Cannabis Affects Thinking and Emotions
Neurophysiological tools measure what is happening inside the brain. These methods allow clinicians to observe how cannabis use impacts regions involved in memory, decision-making, and emotional regulation.
Common tools include:
- MRI and fMRI show structural and metabolic changes in the brain. Research has found differences in areas such as the prefrontal cortex and hippocampus among individuals with CUD.
- EEG measures electrical brain activity. It is especially useful for identifying disruptions in attention and cognitive processing.
- DTI tracks white matter integrity, helping researchers see how communication pathways in the brain may be affected.
- Transcranial Doppler (TCD) evaluates blood flow and can provide insight into how cannabis influences brain vascular function.
These assessments do not require invasive procedures. Instead, they offer a way to observe how the brain changes over time with continued cannabis use or during recovery. When used in clinics, EEG and other neurofeedback tools may help patients learn to regulate brain activity patterns that contribute to cravings or emotional dysregulation.
Psychological Inventories That Help Identify Patterns of Use
In addition to brain-based tools, psychologists rely on standardized self-report questionnaires. These assessments help determine how cannabis use is affecting daily life, emotional well-being, and the ability to control or limit consumption.
Well-supported screening tools include:
- Cannabis Use Disorders Identification Test Revised (CUDIT-R)
- Cannabis Abuse Screening Test (CAST)
- Severity of Dependence Scale (SDS)
- Cannabis Problems Questionnaire (CPQ)
- Marijuana Problem Scale (MPS)
- Cannabis Use Problems Identification Test (CUPIT)
These tools have strong reliability and validity, meaning they produce consistent results and accurately reflect the challenges associated with cannabis use. They are practical for mental health clinics, primary care settings, and research programs.
How Combining These Tools Improves Treatment
Using both neurophysiological assessments and psychological screenings gives a more complete picture of CUD. Brain imaging and EEG provide objective information about neurological changes, while psychological tests offer personal insights into motivations, habits, and distress. When combined, these assessments:
- Support early detection before significant impairment develops
- Help tailor treatment plans to the patient’s specific needs
- Allow clinicians to track progress over time using measurable outcomes
This integrative approach strengthens evidence-based care and improves the chances of meaningful recovery.
Citations:
- Khattak AZ et al. A Systematic Review of Neurophysiological and Self-Report Psychological Inventories for Cannabis Use Disorder. https://pubmed.ncbi.nlm.nih.gov/41212782/
- Volkow ND, Baler RD, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med. https://www.nejm.org/doi/full/10.1056/NEJMra1402309